We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Renumathy Dhanasekaran

Renumathy Dhanasekaran MD

Assistant Professor and Director of Communications, Division of Gastroenterology and Hepatology, Stanford University, Stanford, California

Renumathy Dhanasekaran, MD, is an Assistant Professor in the Division of Gastroenterology and Hepatology at the School of Medicine, Stanford University. Her primary research goal is to explore the molecular biology of liver cancer in order to identify novel biomarkers and molecular-targeted therapies. She conducts basic and translational research to understand the molecular mechanisms of liver cancer metastasis and dormancy using mouse models of liver cancer. Also, she plays an active role in the cancer genome atlas (TCGA) consortium effort to translate the knowledge gained from the study of genomics of liver cancer. She maintains a biorepository of tissue and blood samples from patients with liver cancer and has also developed several patient derived xenograft (PDX) models for preclinical testing. Dr. Dhanasekaran is board certified in Internal Medicine and Gastoenterology. Her clinical practice is mainly focused on liver cancer, and she runs a clinic specifically for patients with liver masses.

Disclosures

Dr. Dhanasekaran has no relevant disclosures.

Recent Contributions to PracticeUpdate:

  1. SARS-CoV-2 Infection in Patients With Autoimmune Hepatitis